Floatz logo

Calcium folinate pentahydrate

Treatment Related Cancer

Ludwig-Maximilians - University of MunichSmall moleculePhase 2Active
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

3 Active assets in the Treatment Related Cancer cohort.

Asset / SponsorPhaseRating
Cetuximab
Ludwig-Maximilians - University of Munich
Phase 2B
FLUOROURACILUM
Ludwig-Maximilians - University of Munich
Phase 2B
PANITUMUMAB
Ludwig-Maximilians - University of Munich
Phase 2CCC
Avelumab
Ludwig-Maximilians - University of Munich
Phase 2CCC
sy001
Cell Origin Biotech (Hangzhou) Co., Ltd.
N/AD

Same molecule, other indications

Calcium folinate pentahydrate is also rated in:

Advanced KRAS Positive Metastatic Colorectal CancerDormant
BBB
Indicative ·
78 / 100
View asset →
Recurrent Pancreatic CarcinomaDormant
BBB
Indicative ·
78 / 100
View asset →
Stage IV Colon CancerDormant
BBB
Indicative ·
77 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →